about
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical ...
Read More
1.18
0.00
(0.00%)
756.6K
XNAS Volume
XNAS 23 Jun, 2026 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
MaxCyte Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..